Overview

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Status:
Active, not recruiting

Trial end date:
2021-05-31

Target enrollment:

Participant gender:

Summary

This phase IV study is a prospective open-label multi-center study to investigate the effect of a temporary individualized poly-pharmaceutical De-escalation treatment with the target to regenerate ß-cell function over 12 weeks on the disease stage and glycemic control in patients with type 2 diabetes. This is an uncontrolled pilot study to collect data for later confirmatory trials.

Phase:

Phase 4

Details

Lead Sponsor:

Sciema UG

Collaborator:

Innovative Diabetes Treatment Studies LLC.

Treatments:

Insulin